SHE:300357 Revenue

Zhejiang Wolwo Bio-Pharmaceutical had revenue of 228.47M CNY in the quarter ending March 31, 2025, with 5.65% growth. This brings the company's revenue in the last twelve months to 937.62M, up 6.39% year-over-year. In the year 2024, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 925.39M with 9.10% growth.

Revenue (ttm)

937.62M

Revenue Growth

+6.39%

P/S Ratio

11.54

Revenue / Employee

558.44K

Employees

1,679

Market Cap

10.82B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	925.39M	77.20M	9.10%
Dec 31, 2023	848.19M	-47.83M	-5.34%
Jan 1, 2023	896.02M	88.32M	10.94%
Dec 31, 2021	807.69M	171.48M	26.95%
Dec 31, 2020	636.21M	-3.14M	-0.49%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Sichuan Biokin Pharmaceutical	5.82B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings